Case Studies Industry

Translate Bio

1 min read 12 Jan 2022

The fast-tracking of mRNA-based vaccines in the face of a real-life global pandemic has been a revelation and one which has opened up possibilities for harnessing mRNA products against a wide range of viruses. The race is now on to develop the next generation of mRNA therapeutics using machine learning and AI techniques for target identification, and the integration of full digitization tools into user-friendly platforms could present significant advantages.

Stepping into this arena is US-based biotechnology company Translate Bio, headquartered in Lexington, Massachusetts, specializing in mRNA products and co-developing vaccines with collaborator Sanofi Pasteur. Its data science manager, Emma McIntosh, has begun organizing the company’s data flows and implementing electronic lab notebooks that bring a whole host of efficiency benefits and help with regulatory compliance.

Learn how Translate Bio (now acquired by Sanofi) uses eLabJournal to speed the development of mRNA-based vaccines.

> Read the full article on SelectScience

What stuck out about the eLabJournal software is that it was so easy for people to lift their process from saving their information to a shared drive to saving it all into an electronic lab notebook.

Emma McIntosh

 

Recommended For you

2 min read 22 Aug 2022

Boston University

Learn how Boston University implemented an in-house COVID-19 testing lab with the adoption of eLabJournal and utilization of eLab API

Read more
1 min read 12 Jan 2022

Translate Bio

Learn how Translate Bio uses eLabJournal to speed the development of mRNA-based vaccines in this SelectScience feature article

Read more
1 min read 12 Jan 2022

Sabeti Lab

Learn how the Sabeti Lab uses eLabJournal to align its research and work remotely to streamline, standardize, and automate protocols.

Read more

Start your journey to an
All Digital Lab today!

Schedule a Personal Demo for friendly expert guidance and a free lab workflow assessment.